Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Reida M El Oakley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Syed, A. U.
Right arrow Articles by Al Fagih, M. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Syed, A. U.
Right arrow Articles by Al Fagih, M. R
Related Collections
Right arrow Coronary disease
Asian Cardiovasc Thorac Ann 2002;10:107-110
© 2002 Asia Publishing EXchange Pte Ltd

ORIGINAL CONTRIBUTIONS

Coronary Bypass Surgery in Patients on Thyroxin Replacement Therapy

Aitizaz Uddin Syed, FRCS, Ahmed F El Watidy, FRCS, Akhlaque N Bhat, FRCS, Ahmed Wahba, MBBS, Reida M El Oakley, FRCS, Imran Kiyani, MBBS, Emad A Al Bukhari, FRCS, Mohammed R Al Fagih, FRCS

Prince Sultan Cardiac Center Armed Forces Hospital Riyadh, Saudi Arabia
Aitizaz Uddin Syed, FRCS Tel: 1 513 636 4770 Fax: 1 513 636 3847 email: aitizaz{at}hotmail.com Department of Cardiothoracic Surgery, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati OH 45229-3039, USA.
The outcome of coronary bypass surgery was analyzed in 25 patients who were on thyroxin replacement therapy for chronic thyroid disorders at the time of operation. It was hypothesized that if such patients were given only their routine dose of thyroxin on the day of surgery, hemodynamic and cardiorespiratory recovery may be poor. All the patients on thyroxin replacement therapy were given their routine dose of thyroxin orally or via a nasogastric tube in the perioperative period. No supplemental dose was used. Based on preoperative levels of thyroid stimulating hormone, 68% of these patients were biochemically hypothyroid prior to surgery. Analysis of a large number of variables showed no difference in outcome against a control group who had no previous thyroid problems. We conclude that routine thyroxin administration is all that is required for a satisfactory outcome in patients undergoing coronary bypass surgery while on thyroxin replacement therapy.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
Q. Fu, H. Zhang, M. Peng, H. Gao, L. Jia, and M. Wei
Off-Pump Coronary Artery Bypass Grafting in Patient with Sheehan's Syndrome
Ann. Thorac. Surg., November 1, 2008; 86(5): 1674 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Haverich, S. K. Shernan, J. H. Levy, J. C. Chen, M. Carrier, K. M. Taylor, F. Van de Werf, M. F. Newman, P. X. Adams, T. G. Todaro, et al.
Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical Patients
Ann. Thorac. Surg., August 1, 2006; 82(2): 486 - 492.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by SAGE Publications